CC
VERA icon

Corton Capital’s Vera Therapeutics VERA Stock Holding History

Corton Capital’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$307K Buy
+10,562
New +$244K 0.75% 22

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Corton Capital's VERA Position: Q3 2025 in Review

Corton Capital opened a new position in Vera Therapeutics (VERA) in Q3 2025: 10,562 shares worth $307K. The stake represents 0.75% of the portfolio and ranks #22 among its holdings.

175 funds tracked by Wall St. Rank hold VERA as of Q3 2025.

  • Corton Capital held 10,562 shares of Vera Therapeutics worth $307K as of Q3 2025.
  • Vera Therapeutics was a new Corton Capital position in Q3 2025.
  • Vera Therapeutics made up 0.75% of Corton Capital's portfolio in Q3 2025, its #22 holding.
  • 175 funds tracked by Wall St. Rank held Vera Therapeutics as of Q3 2025.

Based on Corton Capital's 13F filing for Q3 2025, filed 14 Nov 2025.